Molecular Partners AG Sponsored ADR
MOLN Healthcare Biotechnology
In the quarter to June 2026, revenue fell 98.9%, EPS grew 34.3% and free cash flow grew 23.8%, each against the same quarter a year earlier.
Follow MOLN
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
112.32 | 169.75 | 208.18 | 261.08 | 145.31 | 185.29 | 98.02 | 100.98 | 143.94 | 176.69 |
Receivables |
2.21 | 2.63 | 2.18 | 1.07 | 28.06 | 3.03 | 2.13 | 52.67 | 1.18 | 0.83 |
Other current assets |
2.40 | 2.87 | 4.03 | 4.81 | 6.24 | 1.65 | 2.86 | 2.80 | 0.32 | 0.48 |
Total current assets |
116.93 | 175.25 | 214.38 | 266.95 | 179.64 | 189.65 | 103.01 | 156.45 | 145.43 | 178.00 |
Property, Plant, Equpment (Net) |
6.31 | 4.77 | 6.33 | 7.58 | 8.91 | 10.01 | 4.37 | 1.48 | 1.91 | 2.45 |
Goodwill and Intangible Assets (Total) |
0.00 | 0.06 | 0.24 | 0.28 | 0.36 | 0.37 | 0.80 | 0.39 | 0.03 | 0.05 |
Total non-current assets |
6.31 | 4.82 | 6.56 | 7.87 | 9.27 | 10.38 | — | — | — | — |
Total Assets |
123.24 | 180.07 | 220.94 | 274.82 | 188.92 | 200.04 | 108.18 | 158.32 | — | 180.49 |
Accounts Payable |
2.13 | 2.11 | 1.48 | 2.25 | 8.08 | 6.21 | 2.08 | 2.15 | 0.73 | 1.01 |
Accrued Expenses |
9.72 | 8.76 | 8.41 | 7.86 | 10.91 | 8.23 | — | — | — | — |
Current Part of Debt |
— | — | — | — | — | — | 1.31 | — | — | — |
Current Part of Capital Lease |
1.46 | 1.38 | 1.35 | 1.26 | 1.30 | 1.26 | — | — | — | — |
Other current liabilities |
— | — | 4.83 | 6.72 | 30.98 | 45.81 | 26.10 | 35.47 | 13.70 | 14.45 |
Total current liabilities |
13.31 | 12.25 | 16.06 | 18.08 | 51.28 | 61.51 | 29.49 | 37.62 | 14.43 | 15.46 |
Long Term Debt (Total) |
— | — | — | — | — | — | 1.32 | — | — | — |
Non-current Revenue (Deferred) |
— | — | — | — | — | — | 10.33 | 21.30 | 9.73 | 26.29 |
Pension and Post-Retirement Liabilities |
9.83 | 5.54 | 5.64 | 2.67 | 7.37 | 14.59 | — | — | — | — |
Non-current Liabilities (Other) |
0.19 | — | — | 3.81 | 7.58 | 3.13 | 11.23 | 5.83 | 4.10 | 5.61 |
Total non-current liabilities |
12.97 | 6.94 | 8.36 | 10.31 | 20.26 | 24.16 | — | — | — | — |
Total liabilities |
26.28 | 19.19 | 24.42 | 28.39 | 71.53 | 85.68 | 52.37 | 64.75 | 28.26 | 47.36 |
Additional Paid In Capital |
469.74 | 437.18 | 407.16 | 377.58 | 388.42 | 319.42 | — | — | — | — |
Common Stock (Net) |
4.87 | 4.58 | 4.05 | 3.78 | 3.53 | 3.11 | 2.23 | 2.17 | 2.15 | 2.03 |
Retained Earnings |
(376.29) | (279.76) | (213.60) | (133.90) | (274.56) | (208.17) | (134.92) | (91.69) | (61.96) | (36.53) |
Treasury Stock |
1.36 | 1.11 | 1.09 | 1.03 | — | — | — | — | — | — |
Common Equity (Total) |
96.96 | 160.89 | 196.52 | 246.43 | 117.38 | 114.36 | 55.81 | 93.58 | 119.11 | 133.13 |
Shareholders Equity (Total) |
96.96 | 160.89 | 196.52 | 246.43 | 117.38 | 114.36 | 55.81 | 93.58 | 119.11 | 133.13 |
Shareholders Equity and Liabilities (Total) |
123.24 | 180.07 | 220.94 | 274.82 | 188.92 | 200.04 | — | — | — | — |
Shares (Common) |
40.38 | 40.36 | 36.35 | 36.05 | 32.29 | 32.16 | — | — | — | — |
Shareholders Equity (Tangible) |
96.96 | 160.83 | 196.29 | 246.15 | 117.02 | 113.99 | — | — | — | — |
Net Debt |
(112.32) | (169.75) | (208.18) | (261.08) | (145.31) | (185.29) | (95.40) | (100.98) | (143.94) | (176.69) |
Total Debt |
— | — | — | 5.27 | 6.64 | 8.20 | 2.62 | — | — | — |